Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 465 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
34 Мб
Скачать
58
S. B. Orenstein
process is mostly benecial, excessive brosis can be a detriment, with resultant encapsulation, mesh shrinkage, increased stiffness, and undesirable symptoms for the patient [5]. Conversely, insufcient cellular ingrowth and brosis can lead to poor mesh integration, mesh folding, central mesh failure, and ensuing hernia recur­rence. This chapter will review commonly used meshes and their various character­istics, including material, density, and porosity, among other attributes that contribute to incorporation of the mesh upon implantation.
Synthetic Mesh Characteristics (Table5.1 )
Most prosthetic materials, although chemically inert, generate an intense host inammatory reaction upon implantation. The host response to implanted prosthetic biomaterials follows a typical sequence of events, namely, coagulation, inamma­tion, neovascularization, broplasia, matrix deposition, and wound contraction. Exaggerated inammatory responses with its downstream effects can lead to sig­nicant clinical sequelae, including excessive brosis and persistent foreign body response. In the long term, such acquired rigidity of implanted meshes can contrib­ute to changes in compliance of both the hernia site and the entire abdominal wall. Clinically, this decrease in compliance can lead to a sensation of stiffness and result in both physical discomfort and limitations in the activities of daily living for some patients. The deleterious foreign body effects of synthetic meshes are related to the amount of foreign body implanted. As a result, a goal of modern mesh manufactur­ers has been the development of prosthetic implants that are able to meet the tensile demands of the abdominal wall while limiting the foreign body burden at the site of the repair. As a theme of modern meshes, a reduction of the overall density/weight of the mesh implant has been shown to be associated with an increase in biocompat­ibility of the prosthetic [5].
Material
Polypropylene (PP) remains the most commonly utilized polymer of hernia meshes, and is manufactured by most companies that produce surgical meshes, even if they manufacture other materials. It has the longest track record of any mesh material, being used for over 60years, and has demonstrated long-term dura­bility. Polypropylene remains popular due to its high tensile strength, durability, pliability, and ease of use at time of repair. However, traditional (heavyweight) polypropylene can induce a strong inammatory reaction. Excessive inammation can lead to high levels of brosis, loss of pliability, chronic pain, as well as intoler­ance to infection. Modern lightweight polypropylene meshes obviate many of these drawbacks, with reduced inammation and its sequelae (discussed below). Also, if exposed to viscera, uncoated polypropylene can lead to signicant adhe­sive disease and/or stulae.
5 Permanent Prosthetics: Polypropylene, Polyester, ePTFE, andHybrid Mesh
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 5.1 Synthetic mesh characteristics
Material
Standard Permanent meshes
Polypropylene (PP) Surgipro™ US Surgical/
Polyester (PET) Parietex™ US Surgical/
Polytetrauoroethylene (PTFE)
Polyvinylidene uoride (PVDF)
Mesh product Manufacturer
Mesh characteristics
Heavyweight—110g/m
Covidien/
Microporous—0.6–0.8mm
Medtronic
Prolene™ Ethicon Heavyweight—105g/m
Microporous—0.8+ mm
Prolene Soft™ Ethicon Lightweight—45g/m
Macroporous—2.4mm
Marlex CR Bard Heavyweight—95g/m
Microporous—0.5mm
Bard Mesh™ Bard-Davol Heavyweight—95g/m
Microporous—0.46mm
Bard Soft Mesh™
®
Trelex
Bard-Davol Lightweight—44g/m
Macroporous—2.5mm
Boston Scientic
Heavyweight—95g/m Microporous—0.6mm
ProLite™ Atrium Medium weight—85g/m
Microporous—0.8mm
ProLite Ultra™ Atrium Medium weight—50g/m
Microporous—0.75mm
Parietene™ Covidien/
Medtronic
Parietene™ Macroporous
DynaMesh
Covidien/ Medtronic
®
-PP
DynaMesh Medium weight—72g/m
standard DynaMesh
®
-PP
DynaMesh Ultralightweight—36g/m
light
Medium weight—78g/m Microporous—1.0–1.6mm
Medium weight—46g/m Microporous—2.0–2.4mm
Macroporous—1.4–1.8mm
Macroporous—1.6–2.6mm
3-D multilament PET mesh Covidien/ Medtronic
Medium weight—78g/m
Macroporous—1.0–1.6mm
Mersilene Ethicon 2-D multilament PET mesh
Lightweight—33–40g/m
Macroporous—1.0mm
Parietex™ Lightweight
Covidien/ Medtronic
Monolament PET mesh
Medium weight—46g/m
Macroporous—1.5mm
Versatex™ Medtronic Monolament PET mesh
Medium weight—64g/m
Macroporous—2.1–3.0mm
Innit WL Gore Medium weight—65–70g/m
Macroporous—unknown mm
DynaMesh
®
DynaMesh Density—unknown
Porosity—unknown
59
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
a
a
a
(continued)
60
Table 5.1 (continued)
S. B. Orenstein
Material
Mesh product Manufacturer
Partially resorbable composite meshes
Polypropylene with
Ultrapro™ Ethicon Ultralightweight—28g/m
poliglecaprone
Polypropylene with
Vypro II Ethicon Lightweight—35
polyglactin Polyester with polylactic
ProGrip™ Covidien/
acid (PLA) microgrips
Polyester with polylactic acid (PLA) microgrips
ProGrip™ Laparoscopic
Anti-adhesion and coated composite meshes
Expanded
DualMesh
®
polytetrauoroethylene (ePTFE)
Dulex™ Bard-Davol (solid laminar sheet)
Polypropylene mesh and
Composix E/X™Bard-Davol Heavyweight, microporous
ePTFE
Composix L/P™Bard-Davol Lightweight, macroporous
Ventralex™ Bard-Davol Patch designed for smaller
Polypropylene and
Sepramesh™ Bard-Davol Medium weight polyglycolic acid (PGA) mesh + carboxymethylcellulose­sodium hyaluronate-
Ventralex ST™ Bard-Davol Patch designed for smaller polyethylene glycol
(CMC-HA-PEG) coating
Ventralight
ST™
Mesh characteristics
(~40g/m
2
out of package before poliglecaprone resorption) Macroporous—2.0–4.0mm
Macroporous—3.4mm Monolament polyester with
Medtronic
PLA microgrips Medium weight—38g/m
2
(73g/m
out of package before PLA microgrip absorption) Macroporous—1.1–1.7mm
Covidien/ Medtronic
Monolament polyester with PLA microgrips Medium weight—49g/m
2
(82g/m
out of package before PLA microgrip absorption) Macroporous—1.8mm
WL Gore (solid laminar sheet)
2-sided: micro- and macroporous
2-sided: micro- and macroporous
a
a
polypropylene (abdominal wall surface) and microporous ePTFE (anti-adhesion)
polypropylene (abdominal wall surface) and microporous ePTFE (anti-adhesion)
defects (e.g., umbilical, port site hernias) Weight/pore size—unknown
Macroporous polypropylene Heavyweight—102g/m Pore size—unknown
defects (e.g., umbilical, port site hernias) Weight/pore size—unknown
Bard-Davol Medium weight
Macroporous polypropylene Weight/pore size—unknown
2
2
2
a
2
a
a
a
5 Permanent Prosthetics: Polypropylene, Polyester, ePTFE, andHybrid Mesh
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
61
Table 5.1
Material Polypropylene mesh +
poliglecaprone coating
Polypropylene and polydioxanone (PDS)
(continued)
Mesh product Manufacturer
Physiomesh™ Ethicon Light or ultralightweight—
Mesh characteristics
(estimated 28–40g/m
2)a
Macroporous—unknown mm
Proceed™ Ethicon Lightweight—45g/m
2
Macroporous—unknown mm
a
a
mesh + oxidized regenerated cellulose (ORC) backing
Polypropylene mesh + omega-3 fatty acid coating
C-Qur™ Atrium Medium weight—85g/m
Microporous—0.8mm
C-Qur Lite™ Atrium Medium weight—50g/m
2
2
Microporous—0.75+ mm
3-D Polyester + collagen-polyethylene
Parietex™ Composite
Covidien/ Medtronic
Medium weight—78g/m Macroporous—1.8×1.5mm
2
glycol (PEG) coating Monolament polyester
+ collagen lm Polyvinylidene uoride
(PVDF)+polypropylene
Symbotex™ Composite
DynaMesh IPOM
Medtronic Medium weight—66g/m
Macroporous—2.3–3.3mm
®
DynaMesh Medium/
heavyweight—60/108g/m
2
2
(PP-60/PP+PVDF 108 for overall effective density of both materials) Macroporous—>1mm
Polypropylene + titanium (vapor deposition of titanium)
TiMesh™ strong
PFM Medical Medium weight—65g/m
Macroporous—>1mm
TiMesh™ light PFM Medical Ultralightweight—35g/m
2
2
Macroporous—>1mm
TiMesh™ extralight
PFM Medical Ultralightweight—16g/m
Macroporous—>1mm
2
Hybrid Meshes
®
Polyester + small intestine submucosa (SIS)
Zenapro
Cook Braided polyester backbone
with SIS laminate Weight/pore size—unknown
a
PTFE + PGA:TMC Synecor WL Gore Monofilament PTFE
backbone with PGA:TMC 3D matrix and PGA:TMC anti-adhesion film Weight/pore size—unknown
a
This table represents a summary of commonly utilized hernia meshes. Not every mesh manufac­tured has been included due to lack of information available, low utilization, etc. Some meshes have been listed for reference that are currently not in use. Information was obtained from manu­facturer material as well as published literature. Please note that there are discrepancies among various published values, and manufacturer information was used as the primary source, when available. Weight/density units, g/m
a
Information not available at time of publication
2
. Pore size units, millimeters
62
S. B. Orenstein
Polyester (polyethylene terephthalate (PET)) is a hydrophilic polymer that, like polypropylene, has a long track record of effectiveness for hernia repair. Traditional polyester meshes are multilament, based on 2-dimensional (at) or 3-dimensional constructs. Newer polyester-based meshes have switched to monolament polyester bers with the overall goal of increasing biocompatibility. Traditional multilament polyester meshes are noted to be highly pliable, allowing the surgeon to easily manipulate and conform the mesh to variations of the abdominopelvic walls. Like polypropylene, polyester can lead to signicant inammatory response with ensu­ing heavy brosis, visceral adhesions, and stulae.
Polytetrauoroethylene (PTFE) is a carbon- and uorine-based synthetic hydro­phobic polymer. Most people associate PTFE with nonstick cookware (e.g., Teon). PTFE has been made in two main forms for hernia repair, with most common appli­cation in a laminar sheet, or “expanded” PTFE form (ePTFE). However, knit ber­based PTFE meshes have been developed as well. DualMesh (WL Gore, Newark, DE, USA) is the most widely used solid laminar ePTFE mesh, containing a smooth side as an anti-adhesion barrier and a corrugated side to facilitate ingrowth. ePTFE use has diminished signicantly over the last several years, likely due to its lack of resilience in the setting of infection as well as a signicant brotic and encapsula­tion response to it. A silver chlorhexidine-impregnated version has also been pro­duced to help reduce infectability.
Polyvinylidene uoride (PVDF) is a polymer that, despite having been described for well over a decade, [6] it’s use within the United States is very limited, with greater utilization in Europe (DynaMesh, Aachen, Germany). One of the principal described benets of PVDF is the ability to withstand hydrolysis and degradation compared to other materials such as PP or PET, and additional studies have demon­strated reduced foreign body response to PVDF [6, 7].
Regarding the biologic study of mesh implants, although tissue reactions of biomaterials vary greatly throughout the literature, experience in animal studies demonstrates that polyester-based meshes are a signicant inducer of inamma­tion and appear to induce a severe chronic foreign body reaction [5]. While poly­propylene meshes also demonstrate signicant inammation and some degree of foreign body response, the severity is strikingly less when compared to polyester­based implants. Compared to the ber-based mesh constructs, integration of lami­nar ePTFE mesh within tissues was met more with heavy brosis and encapsulation instead of integration. This has been seen in invivo studies and clinically with excised samples of previously implanted ePTFE demonstrating signicant heavy brosis. In addition, decreased ability for inter-mesh neovascularization may pre­dispose ePTFE mesh to diminished biocompatibility. Heavy brosis and encapsu­lation often leads to mesh shrinkage. Overall, of the more commonly used polymers, polypropylene exhibits the highest degree of tissue biocompatibility followed by ePTFE and polyester. The clinical implications of these ndings are not entirely clear, and no randomized controlled trials have evaluated these mate­rials in a comparative fashion.
5 Permanent Prosthetics: Polypropylene, Polyester, ePTFE, andHybrid Mesh
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
63
Weight/Density
Mesh density, most commonly termed “weight,” is an important determinant of overall structural strength of the mesh. Typically measured in grams per meter squared (g/m2), mesh weight/density is generally categorized as lightweight, medium weight, and heavyweight, though other terms have been described (e.g., ultralightweight). While various density ranges have been described, commonly published density/weight ranges include [8]:
Heavyweight—>90g/m Medium weight—50–90g/m Lightweight—35–50g/m Ultralightweight—<35g/m
2
2
2
2
Studies have shown that traditional heavyweight meshes may have been overen­gineered, with Marlex-type meshes (heavyweight polypropylene) displaying 4–6 times the tensile and burst strength of the native abdominal wall [9]. Such heavy­weight meshes induce a signicant inammatory reaction and ensure exaggerated brotic response, leading to mesh contraction and excessive hardening of the mesh and surrounding tissues which can lead to chronic pain symptoms [5]. This excessive granulomatous reaction around the mesh bers led to the development of lighter, less dense mesh, with a combination of smaller caliber bers and larger spaces (pores) between the mesh bers (see “Porosity” section below) [9]. Such reductions in pros­thetic weight result in reduced inammatory reaction, less brosis, and mesh con­traction, as well as improved compliance and exibility. However, with all the fervor of producing reduced-weight meshes, manufacturers may have swung the pendulum too far and produced meshes too lightweight. Such lightweight meshes may result in central mesh failure, whereby a mechanical failure develops within the mesh, result­ing in fatigue fracture and subsequent hernia recurrence [10]. Therefore, caution should be used with some lightweight meshes for ventral hernia repair, especially in the setting of bridged repairs, and a heavier weight mesh should be considered.
The scientic and clinical evidence for the benets of mesh density is evolving. Animal studies as well as clinical studies support the notion that limiting density/ weight results in marked reduction in foreign body response and overall biocompat­ibility [11]. A prospective randomized trial of inguinal hernia repair demonstrated elevated inammatory markers and oxidative stress in the heavyweight mesh group compared to lightweight implantations [12]. While other studies support the clinical benets of lightweight mesh [13], a long-term study negated such ndings, with equivalence seen at 2years post-TEP inguinal hernia repair [14]. Despite a variety of studies, the majority of studies demonstrate that the implantation of lightweight polypropylene mesh results in decreased chronic discomfort and reduced restriction of physical activities while providing sufcient strength for the reinforcement of hernia repairs.
64
S. B. Orenstein
Porosity
Along with reducing the ber thickness and density, allowing more empty space between the mesh bers also aids in reducing the overall foreign body footprint of the mesh. Following implantation, each mesh ber is surrounded by a granuloma­tous reaction, with some degree of inammation and brosis [5, 9]. Because micro­porous meshes typically contain thicker bers and limited interber spacing, such heavyweight microporous meshes (e.g., Marlex) induce a signicant inammatory and brotic response. The ensuing “bridging” brosis results in excessive scar plate formation, mesh contraction, and loss of pliability [9]. Macroporous meshes, com­monly with light or medium density, allow for reduced bridging brosis with less mesh contraction. Also, larger pore size permits greater uid transport across the mesh, theoretically reducing seroma formation. For perspective, heavyweight poly­propylene (e.g., Marlex) is an example of a microporous mesh with a pore size of
0.6mm, compared to typical lightweight macroporous meshes commonly having pore sizes in the 2–4mm range. Importantly, reduced weight macroporous mono­lament meshes demonstrate an important nding of greater tolerance in the setting of some degree of contamination (Note: greater tolerance, not resistance, to con­tamination). Early data support the use of permanent lightweight macroporous polypropylene meshes in contaminated settings, [15] though there is a lack of con­sensus for this among hernia surgeons.
Filament Design
Meshes are created using materials arranged in either multilament or, more com­monly, monolament design. Multilament meshes, containing bundles of mesh brils, are beneted by increased exibility at time of implantation. However, they can induce heightened inammatory and foreign body reaction. Of more impor­tance is the inability for multilament meshes to withstand contamination and commonly require mesh explantation if infected [16]. This intolerance of multila­ment meshes to contamination is thought to be due to bacteria being trapped between the small interstices of the mesh brils, with insufcient neovasculariza­tion and inability of immune cell access to such small spaces where the pathogens reside [17]. Conversely, monolament meshes tend to be more stiff and rigid upon implantation. However, they demonstrate reduced inammatory and foreign body responses compared to their multilament counterparts, as well as having reduced bacterial adherence [16]. And, while any mesh has the potential for infection and need for mesh explantation, monolament (macroporous lightweight) meshes have demonstrated greater tolerance in the setting of contamination, as discussed in the previous section.
As already mentioned traditional polyester-based meshes such as Parietex (Medtronic, Minneapolis, MN, USA) are composed of multilament bers. However, newer polyester meshes have been designed with monolament bers, including Versatex, Symbotex, and ProGrip (Medtronic), which are manufactured
5 Permanent Prosthetics: Polypropylene, Polyester, ePTFE, andHybrid Mesh
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
65
with similar monolament polyester bers. The overall goal of monolament forms is to increase biocompatibility upon implantation and perhaps increase tolerance to contamination/infection and allow greater vascularity between mesh bers. However, as Petro etal. point out, the use of monolament polyester meshes requires some degree of caution, as central mesh failures and subsequent hernia recurrence were seen with an unusually high rate with the use of a monolament polyester­based mesh [10].
Anti-adhesion Barriers
Because of the inammatory response to foreign materials, the abdominal cavity creates varying degrees of adhesions to implanted prosthetics. In an effort to reduce adhesion formation, mesh manufacturers have developed composite meshes that greatly reduce adhesions and allow intra-abdominal placement of meshes. Common design strategies for intra-abdominal meshes include one side containing some form of tissue-separating barrier designed to impede ingrowth of viscera and adhesions, while the opposite side contains a porous, or a rougher, surface to facilitate ingrowth from the peritoneum.
Various anti-adhesive polymers have been developed including hyaluronic acid (Ventralight ST; Sepramesh, Bard-Davol), polyethylene glycol (Parietex, Medtronic), collagen lm (Symbotex, Medtronic), oxidized regenerated cellu­lose (Proceed), omega-3 fatty acids (C-Qur, Atrium), and poliglecaprone (Physiomesh, Ethicon), among others. These mesh coatings are intended to per­sist until the abdomen has created a neoperitoneum over the visceral side of the mesh, typically within 10–14days after mesh implantation. Of note, the design of Physiomesh (Ethicon, Somerville, NJ, USA) differed greatly from other meshes for use within the abdominal cavity. Instead of only a single-sided coat­ing of poliglecaprone (i.e., Monocryl), both sides contained the poliglecaprone anti-adhesion barrier. This design aw impeded adequate ingrowth from the peri­toneal side and was likely a contributing factor in reported failures and its even­tual removal from the market.
ePTFE is very effective as an anti-adhesion barrier. A common use of ePTFE (e.g., DualMesh, WL Gore, Flagstaff, AZ, USA) is as a bilaminar mesh, with fusion of a “macroporous” rough/corrugated layer to promote tissue ingrowth from the peritoneum, and a smooth “microporous” layer, which impedes adhesions on the visceral surface. Similarly, other meshes have utilized ePTFE as an anti-adhesion barrier, with bare polypropylene serving as the peritoneal, ingrowth side, while the ePTFE impedes adhesions on the visceral size (e.g., Composix, Davol, Warwick, RI, USA). One potential issue with such composite meshes is the differing rates of brosis and contraction of the two completely different materials. ePTFE tends to induce signicant brous encapsulation leading to greater shrinkage of this layer compared to the polypropylene side. This may result in mesh curling and possible exposure of polypropylene bers, leading to worse adhesions, or perhaps hernia recurrence, and may require mesh explantation.
66
S. B. Orenstein
Composite andHybrid Meshes
Many of the meshes described above are composed entirely of permanent polymer bers. However, there are varieties of permanent meshes that also contain resorb­able or other materials. The addition of temporary bers adds initial structural integ­rity at time of implantation and then resorbs as tissue inltrates the mesh. One commonly used example is Ultrapro (Ethicon, Somerville, NJ, USA), which is an ultralightweight polypropylene mesh containing interwoven bers of poliglecap­rone (i.e., Monocryl, Ethicon) that add initial stiffness to the mesh. Ultrapro starts out at ~40g/m tion of the poliglecaprone bers, hence the ultralightweight designation. Similarly, Vypro (Ethicon, Somerville, NJ, USA) consists of both polypropylene bers and polyglactin (i.e., Vicryl) to add initial strength which resorbs (~2–3months) follow­ing implantation. An example of a hybrid/composite mesh for intra-abdominal use is Ventralight ST (Bard-Davol, Warwick, RI, USA), which is a barrier-coated medium weight polypropylene mesh that also contains interwoven polyglycolic acid (PGA) bers. The use of PGA bers allows temporary “thickness” of the mesh, which facilitates adherence of the anti-adhesion hydrogel to the mesh bers. TiMesh (PFM Medical, Nuremberg, Germany) is an interesting polypropylene-based mesh with covalently bound titanium atoms around each mesh ber. The stated benets of the titanium coating include a reduction in inammation and foreign body response, thus improving biocompatibility as well as allowing for intra-abdominal use.
Newer laminate hybrid meshes have been developed that incorporate both a per­manent mesh ber backbone combined with biologic or synthetic-based resorbable components. While the literature is very limited for such products, early data demon­strate safety and efcacy [18]. Zenapro (Cook Medical, Bloomington, IN, USA) is a laminate synthetic-biologic hybrid consisting of a lightweight macroporous polypro­pylene mesh with layered small intestine submucosa (SIS). The biologic SIS acts to “shield” the polypropylene bers upon implantation, allowing for intra-abdominal placement as well as limiting potential contamination of the permanent mesh bers. Synecor (WL Gore) is another hybrid mesh that consists of three different materials: a macroporous monolament PTFE mesh ber backbone surrounded by Gore’s Bio-A resorbable synthetic polyglycolic acid and trimethylene carbonate (PGA/ TMA) matrix, with a PGA/TMA lm on one side to reduce visceral adhesions. The Bio-A matrix facilitates ingrowth, lasting approximately 3–6months. At time of pub­lication, there are no studies evaluating the use of Synecor.
2
out of the package but ends up ~28g/m2 following complete resorp-
Additional Mesh Considerations
Self-Fixating Mesh
One of the challenges of mesh placement during hernia repair is mesh xation. There are multiple methods and devices utilized to xate the mesh area of concern, with sutures and tacks being the most prevalent xation sources. Such xation
5 Permanent Prosthetics: Polypropylene, Polyester, ePTFE, andHybrid Mesh
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
67
methods have the potential drawbacks of increased pain, bleeding, as well as chronic foreign body and granulomatous reactions. In an effort to reduce xation-related complications, manufacturers have developed meshes that utilize a built-in form of xation. The most widely used self-xating mesh, ProGrip (Medtronic, Minneapolis, MN, USA), utilizes monolament polyester-based mesh that is covered with numer­ous absorbable polylactic acid (PLA) micro-hooks, akin to a burr found in nature. The microscopic hooks promote adherence to the surrounding tissue upon implanta­tion and then absorb over ~18months as the mesh allows ingrowth for long-term xation. Much literature on ProGrip has been published, with over 40 studies over the last 8years, mostly involving inguinal hernia repair. While several case series are supportive of the efcacy of ProGrip with potential for reduced pain, several randomized studies and a recent meta-analysis are not as supportive [1921]. The higher-level data point to the principal advantage of self-xating mesh as reduced operative time and found equivalence of pain with traditional inguinal hernia repair methods. One randomized controlled trial (RCT) found a signicantly higher recur­rence rate with the use of ProGrip for open inguinal hernia repair [20]. Very little data exist for self-xating mesh and ventral hernia repair, and no RCTs have been published. Other self-gripping and self-adhering meshes are actively being researched and have been developed with early use in various parts of the world. Though, there is limited access to other self-adhering meshes in the Unites States at this time.
Anisotropy
Various material properties of meshes contribute to the overall mechanical behavior of the repair of hernias. While the differing elasticity of meshes when pulled in different directions (i.e., anisotropy) has not been well dened to date, studies have shown that many commonly used meshes have up to 20-fold differences in their “stretchability” when pulled in perpendicular directions [22]. This may factor into the success of abdominal wall repairs, as the native abdominal wall is roughly twice as elastic in the vertical (craniocaudal) axis versus the transverse/horizontal axis. As a result, mesh implantation may need to be strategic in order to address the differences in both the textile properties of the prosthetic and the physiologic properties of the abdominal wall [22, 23]. Interestingly, mesh labeling or descriptions of anisotropic behavior from manufacturers are lacking for nearly all products on the market today.
Conclusion
Surgical meshes have demonstrated their usefulness for hernia repair over many
decades, with signicant reductions in hernia recurrence upon implantation. A
variety of permanent synthetic surgical mesh prosthetics have been developed,
which offer immediate structural support as well as provide a scaffold for
ingrowth, thus facilitating long-term integration with the body at the site of her-
nia repair. Many mesh products have been produced over the years, with poly-
propylene, polyester, and ePTFE being the most common materials utilized for
Соседние файлы в папке @xirurgi_2025